Psychiatry & Neurology, Clinical Neurophysiology · Guaynabo, PR
NPI
1447286679
Since 2006
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
101 Ave San Pactricio, Maramar Plaza Suite 1270
Guaynabo, PR, 00968
Phone (787) 751-2509
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
180 services
Medicare patients, 2024
65
Average age 67
Drug cost, 2024
$4.1M
8,767 prescriptions
Company payments, 2025
$531
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ignacio L Pita Garcia was code 99214 (office e&m - established), 96 times for 48 patients. In total Ignacio L Pita Garcia billed 180 services in 14 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 96 | 48 | $81.73 | $7,846 |
| 95819 Neurologic | Office | 17 | 17 | $348.72 | $5,928 |
| 95700 Neurologic | Office | 14 | 14 | $181.72 | $2,544 |
| 95708 Neurologic | Office | 14 | 14 | $113.28 | $1,586 |
| 95719 Neurologic | Office | 14 | 14 | $117.08 | $1,639 |
By year: 2022 $30K for 230 services; 2023 $18K for 147 services; 2024 $22K for 180 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ignacio L Pita Garcia prescribed most often to Medicare patients was Levetiracetam, with 843 prescriptions and refills. In total Ignacio L Pita Garcia wrote 8,767 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 843 | 1,508 | 139 | $41K |
| Lamotrigine Generic | 540 | 958 | 92 | $9,822 |
| Lacosamide Generic | 491 | 649 | 74 | $47K |
| Oxcarbazepine Generic | 452 | 764 | 67 | $29K |
| Clonazepam Generic | 389 | 417 | 55 | $4,714 |
| Keppra Levetiracetam | 349 | 402 | 28 | $533K |
| Topiramate Generic | 311 | 581 | 57 | $6,345 |
| Vimpat Lacosamide | 281 | 335 | 38 | $391K |
| Clobazam Generic | 277 | 347 | 47 | $95K |
| Levetiracetam Er Levetiracetam | 273 | 461 | 50 | $24K |
| Donepezil Hcl Generic | 248 | 556 | 64 | $3,625 |
| Memantine Hcl Generic | 222 | 546 | 65 | $6,688 |
| Gabapentin Generic | 207 | 374 | 45 | $2,969 |
| Zonisamide Generic | 196 | 320 | 40 | $8,958 |
| Epidiolex Cannabidiol (Cbd) | 186 | 186 | 19 | $990K |
Brand drugs: 1,954 claims; generic drugs: 6,722 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ignacio L Pita Garcia $531 ($531 in general payments such as food, travel and fees) from 9 companies. The largest payer was Jazz Pharmaceuticals Inc. with $145.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.